Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation
Movement Disorders · 2024-09 · 39 (9) · 1578-1591
DOI: 10.1002/mds.29881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 16.06.2024. Verfasst von Amaia Lasa-Aranzasti und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: GTP-Binding Protein alpha Subunits, Gi-Go, Movement Disorders. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Defects in GNAO1 , the gene encoding the major neuronal G‐protein Gαo, are related to neurodevelopmental disorders, epilepsy, and movement disorders. Nevertheless, there is a poor understanding of how molecular mechanisms explain the different phenotypes.
Objectives
We aimed to analyze the clinical phenotype and the molecular characterization of GNAO1 ‐related disorders.
Methods
Patients were recruited in collaboration with the Spanish GNAO1 Association. For patient phenotyping, direct clinical evaluation, analysis of homemade‐videos, and an online questionnaire completed by families were analyzed. We studied Gαo cellular expression, the interactions of the partner proteins, and binding to guanosine triphosphate (GTP) and G‐protein‐coupled receptors (GPCRs).
Results
Eighteen patients with GNAO1 genetic defects had a complex neurodevelopmental disorder, epilepsy, central hypotonia, and movement disorders. Eleven patients showed neurological deterioration, recurrent hyperkinetic crisis with partial recovery, and secondary complications leading to death in three cases. Deep brain stimulation improved hyperkinetic crisis, but had inconsistent benefits in dystonia. The molecular defects caused by pathogenic Gαo were aberrant GTP binding and hydrolysis activities, an inability to interact with cellular binding partners, and reduced coupling to GPCRs. Decreased localization of Gαo in the plasma membrane was correlated with the phenotype of “developmental and epileptic encephalopathy 17.” We observed a genotype–phenotype correlation, pathogenic variants in position 203 were related to developmental and epileptic encephalopathy, whereas those in position 209 were related to neurodevelopmental disorder with involuntary movements. Milder phenotypes were associated with other molecular defects such as del.16q12.2q21 and I344del.
Conclusion
We highlight the complexity of the motor phenotype, which is characterized by fluctuations throughout the day, and hyperkinetic crisis with a distinct post‐hyperkinetic crisis state. We confirm a molecular‐based genotype–phenotype correlation for specific variants. © 2024 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.
- Pediatric Neurology Research Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.
- Medicine Genetics Group, Vall d'Hebron Research Institute (VHIR), Autonomous University of Barcelona, Barcelona, Spain.
- Department of Pediatrics, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, Paris, France.
- Translational Research Centre in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
ORCID-Profile: Amaia Lasa-Aranzasti, Yonika A Larasati, Gonzalo P Solis, Beatriz De la Casa-Fages, Vladimir L Katanaev, Belén Pérez-Dueñas
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Lasa-Aranzasti, A., Larasati, Y. A., da Silva Cardoso, J., Solis, G. P., Koval, A., Cazurro-Gutiérrez, A., Ortigoza-Escobar, J. D., Miranda, M. C., De la Casa-Fages, B., Moreno-Galdó, A., Tizzano, E. F., Gómez-Andrés, D., Verdura, E., Katanaev, V. L., Pérez-Dueñas, B., & Study Group of GNAO1 patients from Spain (2024). Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation. Movement Disorders, 39(9), 1578-1591. https://doi.org/10.1002/mds.29881
Vancouver
Lasa-Aranzasti A, Larasati YA, da Silva Cardoso J, Solis GP, Koval A, Cazurro-Gutiérrez A, et al. Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation. Movement Disorders. 2024;39(9):1578-1591. doi:10.1002/mds.29881
BibTeX
@article{LasaAranzasti2024,
author = {Lasa-Aranzasti, Amaia and Larasati, Yonika A and da Silva Cardoso, Juliana and Solis, Gonzalo P and Koval, Alexey and Cazurro-Gutiérrez, Ana and Ortigoza-Escobar, Juan Dario and Miranda, Maria Concepción and De la Casa-Fages, Beatriz and Moreno-Galdó, Antonio and Tizzano, Eduardo F and Gómez-Andrés, David and Verdura, Edgard and Katanaev, Vladimir L and Pérez-Dueñas, Belén and Study Group of GNAO1 patients from Spain, Study Group of GNAO1 patients from Spain},
title = {Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {9},
pages = {1578--1591},
doi = {10.1002/mds.29881}
}
EUVIMED